ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 546

$904K Total Retail Price of All Prescriptions

Rank: 4 out of 546

416 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
OMEPRAZOLE 666 437 1 4
SIMVASTATIN 472 310 2 2
LISINOPRIL 460 314 3 1
LEVOTHYROXINE SODIUM 421 317 4 3
METOPROLOL TARTRATE 414 303 5 6
ATORVASTATIN CALCIUM 377 264 6 11
HYDROCODONE-ACETAMINOPHEN 358 156 S3 7 8
HYDROCHLOROTHIAZIDE 329 255 8 7
FUROSEMIDE 318 250 9 5
AMLODIPINE BESYLATE 302 232 10 9
WARFARIN SODIUM 284 251 11 13
METFORMIN HCL 238 151 12 10
ATENOLOL 236 208 13 12
GABAPENTIN 231 102 14 16
PANTOPRAZOLE SODIUM 220 214 15 18
POTASSIUM CHLORIDE 197 143 16 30
ZOLPIDEM TARTRATE 194 123 17 26
CRESTOR 185 115 18 36
ADVAIR DISKUS 172 115 19 20
OXYCODONE HCL 166 90 S2 20 15
GLYBURIDE 158 119 R 21 45
PREDNISONE 152 101 22 29
SERTRALINE HCL 138 102 23 14
AMITRIPTYLINE HCL 136 65 R 24 48
INSULIN SYRINGE 131 100 25 85
ISOSORBIDE MONONITRATE ER 124 97 26 32
DONEPEZIL HCL 121 121 27 31
VENTOLIN HFA 120 66 28 63
OXYCODONE-ACETAMINOPHEN 115 54 S2 29 54
TRAZODONE HCL 111 73 30 25
LANTUS 111 106 30 46
CYMBALTA 108 31 32 37
RANITIDINE HCL 107 55 33 23
LIPITOR 103 71 34 80
PROAIR HFA 99 51 35 27
TAMSULOSIN HCL 98 87 36 35
TRICOR 98 59 36 128
TRAMADOL HCL 98 60 36 19
DIOVAN 97 75 39 65
LACTULOSE 97 60 39 96
LOSARTAN POTASSIUM 93 67 41 24
DIGOXIN 93 81 41 62
LYRICA 90 24 43 69
DEXILANT 88 36 44 109
CARVEDILOL 86 48 45 56
OXYCODONE HCL-ACETAMINOPHEN 86 36 S2 45 101
SPIRONOLACTONE 86 63 45 82
FAMOTIDINE 85 57 48 53
METOPROLOL SUCCINATE 84 66 49 17
SPIRIVA 80 49 50 28
ENALAPRIL MALEATE 77 54 51 59
CYCLOBENZAPRINE HCL 77 28 R 51 34
COMBIVENT 77 31 51 71
MECLIZINE HCL 75 62 54 131
ALENDRONATE SODIUM 69 52 55 38
CELEBREX 69 67 55 122
PAROXETINE HCL 65 56 57 43
ALLOPURINOL 65 44 57 41
CLOPIDOGREL 63 57 59 77
FLUOXETINE HCL 62 45 60 39
METOCLOPRAMIDE HCL 61 13 61 192
LOVASTATIN 61 52 61 22
RISPERIDONE 59 49 63 47
NOVOLOG 57 51 64 142
NEXIUM 56 50 65 52
SINGULAIR 55 38 66 136
NAMENDA 54 54 67 60
ROPINIROLE HCL 54 32 67 64
MELOXICAM 53 22 69 58
AZITHROMYCIN 51 27 70 55
OXYCONTIN 51 18 S2 70 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.